Evaluation of ocrelizumab in older progressive multiple sclerosis patients

Epstein, S., Fong, K. T., De Jager, P. L., Levine, L., Riley, C., Wesley, S., Vargas, W. S., & Farber, R. (2021). Evaluation of ocrelizumab in older progressive multiple sclerosis patients. Multiple Sclerosis and Related Disorders, 55, 103171. https://doi.org/10.1016/j.msard.2021.103171
Authors:
Samantha Epstein
Kathryn T. Fong
Philip L. De Jager
Libby Levine
Claire Riley
Sarah Wesley
Wendy S. Vargas
Rebecca Farber
Affiliated Authors:
Samantha Epstein
Kathryn T. Fong
Philip L. De Jager
Libby Levine
Claire Riley
Sarah Wesley
Wendy S. Vargas
Rebecca Farber
Columbia Affiliation:
Author Keywords:
chronic progressive
disease modifying drugs
immunosenescence
multiple sclerosis
ocrelizumab
elink
Publication Type:
Article
Unique ID:
10.1016/j.msard.2021.103171
PMID:
34329872
DOI:
10.1016/j.msard.2021.103171
Journal:
Multiple Sclerosis and Related Disorders
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: